Cargando…
High‐throughput membrane‐anchored proteome screening reveals PIEZO1 as a promising antibody‐drug target for human esophageal squamous cell carcinoma
BACKGROUND: Esophageal carcinoma is one of the most fatal cancers worldwide. In China, over 90% of esophageal cancer patients are diagnosed with esophageal squamous cell carcinoma (ESCC). Currently, the survival and prognosis of ESCC patients are not satisfying because of insufficient early screenin...
Autores principales: | Qin, Xun, Ni, Zhen, Jiang, Jianjun, Liu, Xiguang, Dong, Xiaoying, Li, Mei, Miao, Kai, Rao, Shuan, Zhang, Wenqing, Cai, Kaican |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554447/ https://www.ncbi.nlm.nih.gov/pubmed/35608274 http://dx.doi.org/10.1002/cam4.4744 |
Ejemplares similares
-
Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
por: Yang, Jianjun, et al.
Publicado: (2020) -
Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression
por: Xiong, Gang, et al.
Publicado: (2020) -
The Current Situation of Esophageal Cancer Staging and Perioperative Strategies Determination in Central and Southern China: A Cross Sectional Survey
por: Lu, Di, et al.
Publicado: (2019) -
The anchor domain is critical for Piezo1 channel mechanosensitivity
por: Vero Li, Jinyuan, et al.
Publicado: (2021) -
Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
por: Shi, Xiaoshun, et al.
Publicado: (2021)